Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

What You Need To Know About AstraZeneca plc Rejecting Pfizer’s Final Offer
Motley Fool
Monday, May 19, 2014 - 8:57am
tags:
M&A, AstraZeneca, Pfizer
Pfizer Goes Passive-Aggressive In Its Bid For AstraZeneca
Forbes
Monday, May 19, 2014 - 8:56am
tags:
Pfizer, AstraZeneca, UK, M&A
AstraZeneca rejects Pfizer's 'final' bid
CNBC
Monday, May 19, 2014 - 8:49am
tags:
AstraZeneca, M&A, Pfizer
Pfizer ups offer for AstraZeneca again, to $119B
Yahoo/AP
Sunday, May 18, 2014 - 8:32pm
tags:
Pfizer, M&A, AstraZeneca
Could a Vaccine-Based Cancer Cure Be Around the Corner?
Motley Fool
Sunday, May 18, 2014 - 10:20am
tags:
Merck, Galena Biopharma, Peregrine Pharmaceuticals
1 Obesity Drug Stock the Market Got Completely Wrong (video)
Motley Fool
Sunday, May 18, 2014 - 10:13am
tags:
Vivus, Qsymia, weight loss, obesity
Could These 3 Biotechs Help Fight the MERS Virus?
Motley Fool
Sunday, May 18, 2014 - 10:11am
tags:
Inovio, Novavax, NanoViricides
Takeda phase 3 trial data shows orteronel plus prednisone improved progression free survival in men with chemotherapy
Pharmabiz
Saturday, May 17, 2014 - 10:46am
tags:
Takeda, orteronel, prostate cancer
Think Like a Brain Surgeon: Dr. Christopher James Offers Fresh Perspectives on Six Exciting Biotechs
IT Business Net
Saturday, May 17, 2014 - 10:38am
tags:
Opexa, Biocryst, Rexahn, Corcept Therapeutics, Ligand Pharmaceuticals, MannKind
Boehringer Ingelheim to Make Clinical Trial Data Available
PharmTech
Saturday, May 17, 2014 - 10:18am
tags:
Boehringer Ingelheim
Deadly Virus Meets Deadly Cancer With Hopeful Results
Forbes
Saturday, May 17, 2014 - 10:02am
tags:
Pfizer Leads $41 Billion of Bond Sales as Yields Decline
Bloomberg
Saturday, May 17, 2014 - 9:58am
tags:
Pfizer
3 Biotech Dividend Darlings for Your Portfolio
Motley Fool
Saturday, May 17, 2014 - 9:56am
tags:
Amgen, PDL Biopharma, Teva Pharmaceuticals
Update on Glaxo's Darapladib
Yahoo/Zacks
Saturday, May 17, 2014 - 9:53am
tags:
GSK, darapladib
Cardax Pharma: Addressing The Growing Inflammation Market With Nature's Answer
Seeking Alpha
Saturday, May 17, 2014 - 9:51am
tags:
Cardax Pharma
Valeant to consider breakup after mega deals -investors
Reuters
Friday, May 16, 2014 - 6:32pm
tags:
Valeant Pharmaceuticals, restructuring, Allergan, M&A
Cardax Pharma: Addressing The Growing Inflammation Market With Nature's Answer
Seeking Alpha
Friday, May 16, 2014 - 3:48pm
tags:
Cardax Pharma, inflammation, astaxanthin
Merrimack Pharmaceuticals: Setting The Record Straight On MM 398
Seeking Alpha
Friday, May 16, 2014 - 3:46pm
tags:
Merrimack Pharmaceuticals, MM-398, metastatic pancreatic cancer
Shire to submit dry eye treatment to U.S. drug regulator
Yahoo/Reuters
Friday, May 16, 2014 - 3:45pm
tags:
Shire, dry eye disease, Lifitegrast
Pfizer seeks early approval for breast cancer drug
Yahoo/AP
Friday, May 16, 2014 - 3:43pm
tags:
breast cancer, Pfizer, palbociclib

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.